Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
15 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/15/3082628/0/en/Century-Therapeutics-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html
28 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/28/3069673/0/en/Century-Therapeutics-Announces-Two-Upcoming-Presentations-at-the-ASGCT-28th-Annual-Meeting.html
15 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/15/3062105/0/en/Century-Therapeutics-to-Host-Live-Fireside-Chat-Focused-on-Newly-Prioritized-Preclinical-Cell-Therapy-Programs-for-Autoimmune-Diseases-and-Cancer-on-Tuesday-April-22-2025.html
19 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/19/3045786/0/en/Century-Therapeutics-Reports-Full-Year-2024-Financial-Results-and-Provides-Business-Update.html
21 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/21/3012514/0/en/Century-Therapeutics-Announces-Investigator-Initiated-Phase-1-2-Trial-of-its-iPSC-derived-iNK-Cell-Therapy-CNTY-101-in-B-cell-Mediated-Autoimmune-Diseases-Sponsored-by-Internationa.html
17 Dec 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/bms-keeps-axing-deals-inked-under-old-leadership-time-culling-cell-therapy-pacts-century
ABOUT THIS PAGE